Clinical Trial Update: Phenytoin as an Augmentation for SSRI Failures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating phenytoin as augmentation for SSRI failures in depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Phenytoin (Phenytoin)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Depression | Phase 4 | Status: COMPLETED